International Pharmaceutical Compliance Summit on Medical Affairs, Clinical Trials, Safety and Publication
Inn at Penn
Philadelphia, PA
March 30 - April 1, 2005
|
SPONSORED BY
|
|
|
For future information about the International Pharmaceutical Compliance Summit on Medical Affairs, Clinical Trials, Safety and Publication, please complete the form below.
|
|
PhRMA MEMBER SPECIAL DISCOUNT
|
The Pharmaceutical Compliance Summit is pleased to offer two special discounted registration arrangements members of the Pharmaceutical Research and Manufacturers of America (PhRMA) to attend the International Pharmaceutical Compliance Summit on Medical Affairs, Clinical Trials, Safety and Publication.
Click here for more details.
|
|
PCF MEMBER SPECIAL DISCOUNT
|
The Pharmaceutical Compliance Summit is pleased to offer two special discounted registration arrangements members of the Pharmaceutical Compliance Forum (PCF) to attend the International Pharmaceutical Compliance Summit on Medical Affairs, Clinical Trials, Safety and Publication.
Click here for more details.
|
KEYNOTE SPEAKERS:
|
John T. Bentivoglio, Esq.
Partner, King & Spalding, Former Special Counsel for Healthcare Fraud, Chief Privacy Officer, United States Department of Justice, Washington, DC
|
|
Arthur L. Caplan, Ph.D.
Director, Center for Bioethics, University of Pennsylvania, Fellow, American Association for the Advancement of Science, The Hastings Center, The College of Physicians of Philadelphia, and The New York Academy of Medicine, Philadelphia, PA
|
|
Dara A. Corrigan, Esq.
Partner, Arnold & Porter, Former Acting Principal Deputy Inspector General, Office of Inspector General, Department of Health and Human Services, Washington, DC
|
|
Patricia M. Danzon, Ph.D.
Celia Z. Moh Professor, Professor of Health Care Systems and Insurance and Risk Management, Wharton School, University of Pennsylvania, Author, Pharmaceutical Price Regulation: National Policies vs. Global Interests, Philadelphia, PA
|
|
Bruce N. Kuhlik, Esq.
Senior Vice President and General Counsel, Pharmaceutical Research and Manufacturers of America, Washington, DC
|
|
Maxwell J. Mehlman, Esq.
Arthur E. Petersilge Professor of Law, Director of the Law-Medicine Center, Case Western Reserve University School of Law,, Professor of Biomedical Ethics, Case Western Reserve University School of Medicine, Cleveland, OH
|
|
James Sheehan, Esq.
Associate United States Attorney, United States Attorney's Office for the Eastern District of Pennsylvania, Philadelphia, PA
|
|
Daniel E. Troy, Esq.
Partner, Sidley Austin Brown & Wood, Former Chief Counsel, Office of the General Counsel, Food and Drug Administration, Washington, DC
|
|
Murray Kopelow MD, MSC, FRCPC
Chief Executive, Accreditation Council for Continuing Medical Education (ACCME), Chicago, IL
|
|
SUMMIT CO-CHAIRS:
|
Jody Ann Noon, RN, JD
Principal, National Life Science Regulatory Practice Leader, Deloitte & Touche, New York, NY
|
|
John K. Iglehart
Founding Editor, Health Affairs, National Correspondent, New England Journal of Medicine, Washington, DC
|
|
Michael P. Swiatocha
Vice President and SPRI Compliance Officer, Schering-Plough Research Institute, Kenilworth, NJ
|
|
Pat Roche
Partner, PricewaterhouseCoopers LLP, Florham Park, NJ
|
|
Brenton L. Saunders, JD, MBA
Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation, Past President, Health Care Compliance Association, Founder, International Association of Privacy Professionals, Kenilworth, NJ
|
|
FEATURED FACULTY:
Grant P. Bagley, MD, JD
Partner, Arnold & Porter, Former Director, Coverage and Analysis Group, HCFA Office of Clinical Standards and Quality, Washington, DC
I. Scott Bass, Esq.
Partner, Sidley Austin Brown & Wood, Washington, DC
Ingo Beinlich, MD
Chief Executive Officer, Accovion, Palo Alto, CA
Kimberly Brandt
Director, Program Integrity Group, Centers for Medicare and Medicaid Services, Baltimore, MD
Michael M. Bregger
Global Director, Life Sciences, Deloitte & Touche LLP, Glen Mills, PA
Stanley Bukofzer, MD
Director and Vice President, Global Medical Affairs, Golbal Research and Development Division, Abbott Laboratories, Abbott Park, IL
Regina Gore Cavaliere, Esq.
Senior Counsel, Compliance, Americas, Bristol-Myers Squibbm Plainsboro, NJ
Margaret K. Feltz
Senior Manager, Corporate Compliance, Purdue Pharma LP, Stamford, CT
Allyson T. Gage, Ph.D.
Associate Director, CNS Therapeutic Area, Forest Research Institute, Jersey City, NJ
Thomas M. Greene, Esq.
Greene and Hoffman, Boston, MA
Judith Hazlewood, MD, MBA,
Director, Pharmaceutical and Medical Products Practice, McKinsey & Company, Florham Park, NJ
Sharon A. Henry, MD
Vice President, Medical Services and External Affairs, Bristol-Myers Squibb, Plainsboro, NJ
Robert G. Homchick, Esq.
Partner and Chair, Health Law Group, Davis Wright Tremaine, Seattle, WA
Leonard Jokubaitis, MD
Vice President, Data Generation, Janssen Ortho McNeil Scientific Affairs, Titusville, NJ
Paul Kalb, JD, MD
Partner, Sidley, Austin, Brown and Wood, Washington, DC
Jonathon L. Kellerman
Director, Pharmaceutical Advisory Services Group, PricewaterhouseCoopers, Philadelphia, PA
Richard F. Kingham, Esq.
Partner, Covington & Burling, Washington, DC
Mark Allen Kleiman, Esq.
Lawyer, Law Offices of Mark Allen Kleiman, Los Angeles, CA
Christine Laine, MD, MPH
Senior Deputy Editor, Annals of Internal Medicine, Philadelphia, PA
Jon D. Leibowitz
Managing Director, M|C Communications (PriMed), Boston, MA
Gregory H. Levine
Partner, Arnold & Porter, Former Staff, House of Representatives and Former Congressional Staff Liaison to the White House on Health Care Reform Issues, Washington, DC
Stephen Meagher, Esq.
Partner, Law Offices of Stephen Meagher, San Francisco, CA
Michael Mentesana
Director, Pharmaceutical Operations, PricewaterhouseCoopers, LLP, New York, NY
Louis A. Morris, Ph.D.
Louis A. Morris & Associates, Inc., Member, FDA Drug Safety and Risk Management Advisory Committee, Dix Hills, NY
Vatsa Natarajan
Program Manager, Vertex Pharmaceuticals, Cambridge, MA
Tim Nugent
Director, Pharmaceutical Advisory Practice, PricewaterhouseCoopers, Florham Park, NJ
Magali Reyes-Harde, MD, Ph.D.
Clinical Director, CNS-Pain Therapeutic Area, Johnson & Johnson Pharmaceutical Research and Development, Titusville, NJ
Brian Riewerts
Director, Pharmaceutical Advisory Services Group, PricewaterhouseCoopers LLP, Florham Park, NJ
Pat Roche
Partner, PricewaterhouseCoopers LLP, Florham Park, NJ
Brian S. Salsberg, JD
Associate Principal, Pharmaceutical and Medical Products Practice, McKinsey & Company, Florham Park, NJ
William A. Sarraille, Esq.
Partner, Sidley Austin Brown & Wood, Washington, DC
John D. Shakow, Esq.
Counsel, King & Spalding LLP, Washington, DC
David S. Shrager
Partner, Shrager Spivey & Sachs, Philadelphia, PA
Eric Siegel
Chief Compliance Officer, Cephalon, West Chester, PA
Robert Steinbrook, MD
National Correspondent, Former Deputy Editor, New England Journal of Medicine, Boston, MA
Michael A. Swit, Esq.
Vice President, Life Sciences, The Weinberg Group Inc., Encinitas, CA
Robert Temple, MD (Invited)
Director, Office of Medical Policy, Center for Drug Evaluation and Research, Director, Office of Drug Evaluation, Food and Drug Administration, Rockville, MD
Sharon F. Terry, MA
President and Chief Executive Officer, Genetic Alliance, Washington, DC
Sheryl Vacca, CHC
West Coast Life Science and Health Care Regulatory Practice Leader, Deloitte & Touche LLP, Immediate Past President, Health Care Compliance Association, Los Angeles, CA
Mark J. Wanda, Esq.
Vice President, Legal Affairs, Sepracor Inc., Marlborough, MA
|
|
